Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract

Carcinogenesis

Volumn 25, Issue 5, 2004, Pages 793-799

  Almahmeed, Taghreed ^a   Boyle, Jay O ^a   Cohen, Erik G ^a   Carew, John F ^b   Du, Baoheng ^b   Altorki, Nasser K ^b   Kopelovich, Levy ^c   Fang, Jia Long ^d   Lazarus, Philip ^d   Subbaramaiah, Kotha ^b,e   Dannenberg, Andrew J ^b,e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e STRANG CANCER PREVENTION CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE DERIVATIVE; CYCLOOXYGENASE 2; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; PHENOL DERIVATIVE;

ARTICLE; CANCER RISK; CARCINOGENICITY; CELL CULTURE; CELL LINE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIGESTIVE SYSTEM; ENZYME ANALYSIS; ENZYME INDUCTION; GENOTYPE; HUMAN; HUMAN CELL; LARYNX CANCER; MOUTH CANCER; PRIORITY JOURNAL; SMOKING;

ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CARCINOMA, SQUAMOUS CELL; CELL LINE; CYCLOOXYGENASE 2; CYTOCHROME P-450 CYP1A1; GLUCURONIDES; HUMANS; ISOENZYMES; LEUKOPLAKIA, ORAL; MEMBRANE PROTEINS; MOUTH MUCOSA; MOUTH NEOPLASMS; PHENOLS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TONGUE;

EID: 2442625584     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh078     Document Type: Article

References (47)

1. Hu,Z. and Wells,P.G. (1992) In vitro and in vivo biotransformation and covalent binding of benzo[a]pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. J. Pharmacol. Exp. Ther., 263, 334-342.
2. Burke,M.D., Vadi,H., Jernstrom,B. and Orrenius,S. (1977) Metabolism of benzo[a]pyrene with isolated hepatocytes and the formation and degradation of DNA-binding derivatives. J. Biol. Chem., 252, 6424-6431.
3. Bock,K.W., Bock-Hennig,B.S., Lilienblum,W. and Volp,R.F. (1981) Release of mutagenic metabolites of benzo[a]pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide. Chem. Biol. Interact., 36, 166-177.
4. Guengerich,F.P., Hosea,N.A., Parikh,A., Bell-Parikh,L.C., Johnson,W.W., Gillam,E.M. and Shimada,T. (1998) Twenty years of biochemistry of human P450s: purification, expression, mechanism and relevance to drugs. Drug Metab. Dispos., 26, 1175-1178.
5. Guengerich,F.P. and Shimada,T. (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutat. Res., 400, 201-213.
6. Shimada,T., Hayes,C.L., Yamazaki,H., Amin,S., Hecht,S.S., Guengerich,F.P. and Sutter,T.R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56, 2979-2984.
7. Eling,T.E. and Curtis,J.F. (1992) Xenobiotic metabolism by prostaglandin H synthase. Pharmac. Ther., 53, 261-273.
8. Wiese,F.W., Thompson,P.A. and Kadlubar,F.F. (2001).Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis, 22, 5-10.
9. Dannenberg,A.J., Altorki,N.K., Boyle,J.O., Dang,C., Howe,L.R., Weksler,B.B. and Subbaramaiah,K. (2001). Cyclo-oxygenase-2: a pharmacological target for the prevention of cancer. Lancet Oncol., 2, 544-551.
10. Subbaramaiah,K. and Dannenberg,A.J. (2003) Cyclooxygenase-2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci., 24, 96-102.
11. Degawa,M., Stern,S.J., Martin,M.V., Guengerich,F.P., Fu,P.P., Ilett,K.F., Kaderlik,R.K. and Kadlubar,F.F. (1994) Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res., 54, 4915-4919.
12. Ko,Y., Abel,J., Harth,V. et al. (2001) Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res., 61, 4398-4404.
13. Chan,G., Boyle,J.O., Yang,E.K. et al. (1999) Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59, 991-994.
14. Nemoto,N., Takyama,S., Nagao,M. and Umezawa,K. (1978) Modification of the mutagenicity of benzo[a]pyrene on bacteria by substrates of enzymes producing water soluble conjugates. Toxicol. Lett., 2, 205-210.
15. Hu,Z. and Wells,P.G. (1992) In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. J. Pharmacol. Exp. Ther., 263, 334-342.
16. Guillemette,C., Ritter,J.K., Auyeung,D.J., Kessler,F.K. and Housman,D.E. (2000) Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics, 10, 629-644.
17. Jin,C.J., Miners,J.O., Burchell,B. and Mackenzie,P.I. (1993) The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetyl-aminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis, 14, 2637-2639.
18. Mojarrabi,B. and Mackenzie,P.I. (1998) Characterization of two UDP-glucuronosyltransferases that are predominantly expressed in human colon. Biochem. Biophys. Res. Commun., 247, 704-709.
19. Strassburg,C.P., Strassburg,A., Nguyen,N., Li,Q., Manns,M.P. and Tukey,R.H. (1999) Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem. J., 338, 489-498.
20. Zheng,Z., Park,J.Y., Guillemette,C., Schantz,S.P. and Lazarus,P. (2001) Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J. Natl Cancer Inst., 93, 1411-1418.
21. Elahi,A., Bendaly,J., Zheng,Z., Schantz,S.P., Muscat,J.E., Richie,J.P.,Jr and Lazarus,P. (2003) UGT1A10 polymorphisms and potential association with risk for orolaryngeal cancer. Cancer, 15, 872-880.
22. Murray,G.I., Melvin,W.T., Greenlee,W.F. and Burke,M.D. (2001) Regulation, function and tissue-specific expression of cytochrome P450 CYP1B1 Annu. Rev. Pharmacol. Toxicol., 41, 297-316.
23. Spink,D.C., Katz,B.H., Hussain,M.M., Spink,B.C., Wu,S.J., Liu,N., Pause,R. and Kaminsky,L.S. (2002) Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite. Drug Metab. Dispos., 30, 262-269.
24. Kelley,D.J., Mestre,J.R., Subbaramaiah,K., Sacks,P.G., Schantz,S.P., Tanabe,T., Inoue,H., Ramonetti,J.T. and Dannenberg,A.J. (1997) Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis, 18, 795-799.
25. Fang,J.-L., Beland,F.A., Doerge,D.R., Wiener,D., Guillemette,C., Marques,M.M. and Lazarus,P. (2002) Characterization of benzo[a]-pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed human UDP-glucuronosyltransferase enzymes. Cancer Res., 62, 1978-1986.
26. Sacks,P.G. (1996) Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev., 15, 27-51.
27. Sacks,P.G., Parnes,S.M., Gallick,G.E., Mansouri,Z., Lichtner,R., Satya-Prakash,K.L., Pathak,S. and Parsons,D.F. (1988) Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res., 48, 2858-2866.
28. Mitsudomi,T., Viallet,J., Mulshine,J.L., Linnoila,R.I., Minna,J.D. and Gazdar,A.F. (1991) Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6, 1353-1362.
29. Lowry,O.H., Rosebrough,N.J., Farr,A.L. and Randell,R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
30. Laemmli,U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
31. Towbin,H., Staehelin,T. and Gordon,J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
32. Kumar,M.B., Ramadoss,P., Reen,R.K., Vanden Heuvel,J.P. and Perdew,G.H. (2001) The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity. J. Biol. Chem., 276, 42302-42310.
33. Mestre,J.R., Subbaramaiah,K., Sacks,P.G., Schantz,S.P., Tanabe,T., Inoue,H. and Dannenberg,A.J. (1997) Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. Cancer Res., 57, 1081-1085.
34. Thier,R., Bruning,T., Roos,P.H. and Bolt,H.M. (2002) Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer? Arch. Toxicol., 76, 249-256.
35. Strassburg,C.P., Strassburg,A., Nguyen,N., Li,Q., Manns,M.P. and Tukey,R.H. (1999) Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem. J., 338, 489-498.
36. Vogel,A., Ockenga,J., Ehmer,U., Barut,A., Kramer,F.-J., Tukey,R.H., Manns,M.P. and Strassburg,C.P. (2002) Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer. Z. Gastroenterol., 40, 497-502.
37. Zheng,Z., Fang,J.-L. and Lazarus,P. (2002) Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab. Disp., 30, 397-403.
38. Strassburg,C.P., Vogel,A., Kneip,S., Tukey,R.H. and Manns,M.P. (2002) Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut, 50, 851-856.
39. Vogel,A., Kneip,S., Barut,A., Ehmer,U., Tukey,R.H., Manns,M.P. and Strassburg,C.P. (2001) Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology, 121, 1136-1144.
40. Vondracek,M., Xi,Z., Larsson,P., Baker,V., Mace,K., Pfeifer,A., Tjalve,H., Donato,M.T., Gomez-Lechon,M.J. and Grafstrom,R.C. (2001) Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis, 22, 481-488.
41. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem., 276, 18075-18081.
42. Ben-Av,P., Crofford,L.J., Wilder,R.L. and Hla,T. (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett., 372, 83-87.
43. Tsujii,M., Kawano,S., Tsuji,S., Sawaoka,H., Hori,M. and DuBois,R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
44. Tsujii,M., Kawano,S. and DuBois,R.N. (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl Acad. Sci. USA, 94, 3336-3340.
45. Dohadwala,M., Luo,J., Zhu,L., Lin,Y., Dougherty,G.J., Sharma,S., Huang,M., Pold,M., Batra,R.K. and Dubinett,S.M. (2001) Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J. Biol. Chem., 276, 20809-20812.
46. Tsujii,M. and DuBois,R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
47. 2 in human colon cancer cells. Cancer Res., 58, 362-366.